chronic atrophic gastritis
Conditions
Interventions
Chinese medicine group:take Weiweiqing Granules
The western medicine group:Taking folic acid tablets
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: To simultaneously satisfy the following criteria: 1. to meet the chronic atrophic gastritis diagnostic criteria of Western medicine; 2. Aged between 18-65 years old; 3. being able to speaking and reading Chinese to communicate and to fill in the questionnaire; 4. signed the informed consent.
Exclusion criteria
Exclusion criteria: Meet one of the following criteria were excluded: 1. there is explanation above the clinical symptoms of the patients with other diseases; 2. chronic esophagitis, Barrett esophagus and gastroesophageal reflux disease, peptic ulcer, gastric polyp (without resection), digestive tract tumor patients; 3. found that endoscopic gastric mucosa high grade intraepithelial neoplasia, pathological diagnosis, malignant gastrointestinal organic diseases; 4. patients with history of abdominal operation; 5. allergic or allergic to many medicines; 6. confusion, dementia, psychosis, neurosis and various serious unwilling to cooperate; 7. with serious the primary cardiovascular disease, liver disease, kidney disease, blood disease, lung disease, autoimmune diseases, or serious diseases affected the survival, such as cancer or aids; 8. pregnant and lactating women; 9. exist cognitive or other damage (such as vision, etc.) and impact on the participants completed self-report; 10. of the pharmaceutical composition ingredients allergies are; is or 4 weeks in other drug clinical trials of patients; 11. investigators have sufficient reason to believe that the participants according to current medical or psychological state is not suitable for researchers to study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastroscope and Histopathological index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum pepsinogen I and II;The main symptom score;The outcome scale reported by doctor ;The outcome scale reported by patient; | — |
Countries
China
Contacts
Public ContactLIU Feng-bin
Guangzhou University of Chinese Medicine
Outcome results
None listed